Loading organizations...
Innovative drug research and development for cancer treatment.
Hinova Pharma has raised $147.6M across 1 funding round.
Hinova Pharma has raised $147.6M in total across 1 funding round.
Hinova Pharma has raised $147.6M in total across 1 funding round.
Hinova Pharma's investors include DNV Capital, Huarong Rongde, Infinity Group, Tigermed.
Hinova Pharma has raised $147.6M across 1 funding round. Most recently, it raised $147.6M Series C in October 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 7, 2020 | $147.6M Series C | DNV Capital, Huarong Rongde, Infinity Group, Tigermed |